Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2850
+0.0030 (1.06%)
At close: Oct 8, 2025, 4:00 PM EDT
0.2801
-0.0049 (-1.72%)
After-hours: Oct 8, 2025, 7:56 PM EDT
INTS's stock price has decreased by -92.48% in the past year and price targets may not have had time to catch up.
Intensity Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$4.50
Upside
+1,478.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $4 → $1.5 | Buy | Maintains | $4 → $1.5 | +426.32% | Aug 20, 2025 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $3 | Hold → Strong Buy | Upgrades | $3 | +952.63% | Aug 12, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +2,882.46% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,654.39% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +1,654.39% | Oct 31, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,110.53% | Jul 11, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,110.53% | May 16, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,110.53% | Mar 21, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,110.53% | Nov 14, 2023 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,110.53% | Aug 24, 2023 |
| Benchmark | Benchmark | Buy Initiates $12 | Buy | Initiates | $12 | +4,110.53% | Jul 18, 2023 |